Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D3GD1L
|
|||
| Drug Name |
Octahydrocurcumin
|
|||
| Synonyms |
36062-07-4; 1,7-bis(4-hydroxy-3-methoxyphenyl)heptane-3,5-diol; SCHEMBL645293; MEGxp0_001209; MEGxp0_001210; (3S,5S)-1,7-BIS(4-HYDROXY-3-METHOXYPHENYL)HEPTANE-3,5-DIOL; CHEMBL1087517; ACon1_001058; ACon1_001138; DTXSID40873750; HY-N0894; MFCD25371921; AKOS030526791; CS-3740; NCGC00169640-01; NCGC00169640-02; 1,7-Bis(3-methoxy-4-hydroxyphenyl)heptane-3,5-diol; 1,7-Bis(4-hydroxy-3-methoxyphenyl)-3,5-heptanediol; BRD-A35096796-001-01-0; BRD-A35096796-001-02-8; 3,5-dihydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)heptane
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H28O6
|
|||
| Canonical SMILES |
COC1=C(C=CC(=C1)CCC(CC(CCC2=CC(=C(C=C2)O)OC)O)O)O
|
|||
| InChI |
1S/C21H28O6/c1-26-20-11-14(5-9-18(20)24)3-7-16(22)13-17(23)8-4-15-6-10-19(25)21(12-15)27-2/h5-6,9-12,16-17,22-25H,3-4,7-8,13H2,1-2H3
|
|||
| InChIKey |
OELMAFBLFOKZJD-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 36062-07-4
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Octahydrocurcumin, a final hydrogenated metabolite of curcumin, possesses superior anti-tumor activity through induction of cellular apoptosis. Food Funct. 2018 Apr 25;9(4):2005-2014. | |||
| REF 2 | Therapeutic strategies targeting FOXO transcription factors. Nat Rev Drug Discov. 2021 Jan;20(1):21-38. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.